Otto Bollinger contributed to 19th-century pathology by identifying the specific biological origins of bovine actinomycosis, widely recognized today as Actinomyces bovis. Working from his base in Germany, he bridged the gap between veterinary medicine and human clinical pathology, providing foundational observations on infectious diseases and delayed neurological injuries that shifted diagnostic understanding during an era of rapid medical transition.
Academic and Professional Trajectory
Born in Altenkirchen in 1843, Otto Bollinger pursued an education at Leipzig University and Humboldt-Universität zu Berlin. After completing his doctorate in 1868 and earning his habilitation two years later, he held teaching roles at the Tierärtzliche Hochschule in Zürich and the Tierarzneischule in Munich. In 1880, he achieved the rank of professor of general pathology and pathological anatomy at Ludwig-Maximilians-Universität München, succeeding Ludwig von Buhl. His academic career was marked by membership in professional organizations including the Corps Suevia München and the Royal Academy of Medicine of Belgium.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Veterinary Research and Etiology
Bollinger leveraged his deep background in veterinary medicine to isolate the cause of bovine actinomycosis in 1877, identifying the agent now known as Actinomyces bovis. His laboratory studies also encompassed the investigation of rabies before the introduction of a preventative vaccine. Furthermore, his research into fowlpox led to the identification of specific inclusion bodies within tissue cells, which remain designated as Bollinger bodies in veterinary pathology literature. His work extended to the study of botryomycosis, where he categorized the micrococci-containing clusters identified as Bollinger granules.
Clinical Observations in Neurology
In 1891, Bollinger detailed a medical phenomenon he termed "traumatische Spät-Apoplexie," an early analysis of delayed traumatic apoplexy. His documentation relied on case studies of four patients who experienced significant head trauma followed by a fatal apoplectic event occurring weeks later. Medical practitioners now classify this condition as a delayed traumatic intracerebral hematoma (DTICH). This research reflected his focus on the intersection of trauma and pathology, providing a basis for later understandings of intracranial bleeding.
Fast facts
- Born: 1843, Altenkirchen, Germany
- Died: 1909, Munich, Germany
- Degrees: Doctorate, Habilitation
- Key Discovery: Actinomyces bovis
- Academic Home: Ludwig-Maximilians-Universität München
- Medical Focus: Pathology and Surgery
Questions readers ask
What is the primary medical discovery associated with Otto Bollinger?
He is recognized for identifying the etiologic agent of bovine actinomycosis, which is now classified as Actinomyces bovis.
What did Bollinger mean by traumatische Spät-Apoplexie?
He used this term to describe what is now known as a delayed traumatic intracerebral hematoma, characterized by fatal bleeding days or weeks after an initial head injury.
Achievements
- Held posts at Ludwig-Maximilians-Universität München
.jpg)